• Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional)
  (RFA-AA-21-001)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): March 15, 2021  

• Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 – Clinical Trials Not Allowed)
  (RFA-DA-21-040)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below. 
   
• Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 – Clinical Trials Not Allowed)
  (RFA-DA-21-041)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.

• NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required)
  (PAR-21-094)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): February 8, 2021; June 8, 2021; October 8, 2021; February 8, 2022; June 7, 2022; October 7, 2022; February 6, 2023; June 8, 2023; October 10, 2023 apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  
• NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed)
  (PAR-21-095)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): February 8, 2021; June 8, 2021; October 8, 2021; February 8, 2022; June 7, 2022; October 7, 2022; February 6, 2023; June 8, 2023; October 10, 2023 apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
   
• NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)
  (PAR-21-096)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): February 8, 2021; June 8, 2021; October 8, 2021; February 8, 2022; June 7, 2022; October 7, 2022; February 8 2023; June 8, 2023; October 10, 2023 apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
   
• Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease (AD) and AD-Related Dementias (T32)
  (PAR-21-112)
  National Institute on Aging
  Application Receipt Date(s): May 25, 2021; Sep 27, 2021; May 25, 2022; Sep 26, 2022; May 25, 2023; Sep 25, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.  

• Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
  (PAR-21-139)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): March 17, 2021 All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.  

• Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U2F) Clinical Trials Not Allowed
  (RFA-FD-21-028)
  Food and Drug Administration
  Application Receipt Date(s): March 22, 2021, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.  

• Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed)
  (RFA-RM-21-001)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 6, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.  

• Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-21-002)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 06, 2021  

• Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-21-003)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 06, 2021  

• Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional)
  (RFA-RM-21-004)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 06, 2021 
   

• Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required)
  (RFA-RM-21-005)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 06, 2021  

• Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-21-006)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): April 06, 2021